Analyst Consensus ?
ConsensusBuy29 ratings
Bullish2275.9%
Neutral724.1%
Bearish00.0%
FN2 Earnings Intelligence
GE Vernova Inc. complete analyst coverage
GE Vernova Inc. (GEV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$921.27Current
$160Low
$836.1Average
$1,450High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 23, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 11, 2026 |
| BNP Paribas | Neutral | Outperform | Downgrade | Apr 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 23, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 13, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 9, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 31, 2026 |
| Rothschild & Co | Buy | Sell | Upgrade | Mar 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 29, 2026 |
| GLJ Research | Buy | Buy | Maintain | Jan 12, 2026 |
| Seaport Global | Neutral | Buy | Downgrade | Dec 11, 2025 |
| UBS | Buy | Buy | Maintain | Dec 10, 2025 |
| B of A Securities | Buy | Buy | Maintain | Dec 10, 2025 |
| Mizuho | Neutral | Neutral | Maintain | Oct 24, 2025 |
| Melius Research | Buy | Hold | Upgrade | Sep 15, 2025 |
| HSBC | Hold | Hold | Maintain | Sep 5, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 13, 2025 |
| Truist Securities | Buy | Buy | Maintain | Jan 23, 2025 |
| Daiwa Capital | Buy | Outperform | Maintain | Oct 30, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 2, 2024 |
Named analyst price targets
Upside is calculated against the persisted current price $921.27. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Maheep Mandloi | $949 | $1,020.52 | +3.0% | Jul 24, 2026 |
| RBC Capital | Analyst unavailable | $1,225 | $1,002.04 | +33.0% | Jul 23, 2026 |
| Oppenheimer | Analyst unavailable | $1,338 | $1,020.58 | +45.2% | Jul 23, 2026 |
| Guggenheim | Joseph Osha | $1,450 | $985.03 | +57.4% | Jul 23, 2026 |
| Bernstein | Sunaina Ocalan | $1,298 | $985.03 | +40.9% | Jul 23, 2026 |
| Bernstein | Sunaina Ocalan | $1,206 | $982.35 | +30.9% | Jun 16, 2026 |
| Bernstein | Sunaina Ocalan | $1,208 | $982.35 | +31.1% | Jun 16, 2026 |
| Jefferies | Julian Dumoulin-Smith | $1,210 | $901.02 | +31.3% | Jun 11, 2026 |
| Argus Research | John Eade | $1,300 | $1,107 | +41.1% | Apr 27, 2026 |
| BNP Paribas | Analyst unavailable | $1,190 | $1,149.19 | +29.2% | Apr 27, 2026 |
| Goldman Sachs | Analyst unavailable | $1,328 | $1,149.53 | +44.1% | Apr 24, 2026 |
| Jefferies | Julien Dumoulin-Smith | $1,350 | $1,149.53 | +46.5% | Apr 24, 2026 |
| Oppenheimer | Analyst unavailable | $1,303 | $1,150.74 | +41.4% | Apr 23, 2026 |
| RBC Capital | Analyst unavailable | $1,195 | $1,153.57 | +29.7% | Apr 23, 2026 |
| BMO Capital | Analyst unavailable | $1,250 | $1,127.56 | +35.7% | Apr 23, 2026 |
| Susquehanna | Analyst unavailable | $1,300 | $1,127.56 | +41.1% | Apr 23, 2026 |
| Guggenheim | Joseph Osha | $1,300 | $1,127.56 | +41.1% | Apr 23, 2026 |
| Robert W. Baird | Ben Kallo | $1,400 | $1,127.56 | +52.0% | Apr 23, 2026 |
| Barclays | Julian Mitchell | $1,250 | $1,127.56 | +35.7% | Apr 23, 2026 |
| Oppenheimer | Colin Rusch | $1,139 | $982.74 | +23.6% | Apr 16, 2026 |
| Susquehanna | Charles Minervino | $1,080 | $968.02 | +17.2% | Apr 9, 2026 |
| Redburn Partners | Analyst unavailable | $1,100 | $830.1 | +19.4% | Mar 9, 2026 |
| Robert W. Baird | Ben Kallo | $923 | $780.25 | +0.2% | Feb 4, 2026 |
| Mizuho Securities | Analyst unavailable | $714 | $754.97 | -22.5% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $849 | $726.37 | -7.8% | Feb 2, 2026 |
| RBC Capital | Analyst unavailable | $800 | $717.39 | -13.2% | Jan 30, 2026 |
| Guggenheim | Analyst unavailable | $910 | $717.39 | -1.2% | Jan 30, 2026 |
| UBS | Analyst unavailable | $936 | $694.64 | +1.6% | Jan 29, 2026 |
| UBS | Analyst unavailable | $871 | $708.31 | -5.5% | Jan 29, 2026 |
| Evercore ISI | Alexander Virgo | $905 | $707.73 | -1.8% | Jan 29, 2026 |
| Robert W. Baird | Analyst unavailable | $701 | $711.59 | -23.9% | Jan 29, 2026 |
| BMO Capital | Analyst unavailable | $785 | $711.59 | -14.8% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $820 | $711.59 | -11.0% | Jan 29, 2026 |
| Jefferies | Julian Dumoulin-Smith | $930 | $688.5 | +0.9% | Jan 29, 2026 |
| Goldman Sachs | Analyst unavailable | $925 | $711.59 | +0.4% | Jan 29, 2026 |
| Morgan Stanley | David Arcaro | $817 | $657.78 | -11.3% | Jan 26, 2026 |
| GLJ Research | Austin Wang | $1,087 | $622.5 | +18.0% | Jan 12, 2026 |
| Robert W. Baird | Ben Kallo | $649 | $628.4 | -29.6% | Jan 9, 2026 |
| Barclays | Analyst unavailable | $830 | $686.33 | -9.9% | Jan 7, 2026 |
| Jefferies | Julien Dumoulin-Smith | $830 | $658.28 | -9.9% | Dec 22, 2025 |
| Robert W. Baird | Analyst unavailable | $816 | $650.82 | -11.4% | Dec 18, 2025 |
| Jefferies | Analyst unavailable | $815 | $614.19 | -11.5% | Dec 18, 2025 |
| Goldman Sachs | Joe Ritchie | $840 | $681.35 | -8.8% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $822 | $681.35 | -10.8% | Dec 16, 2025 |
| Wells Fargo | Michael Blum | $831 | $681.35 | -9.8% | Dec 16, 2025 |
| Evercore ISI | Alexander Virgo | $860 | $672.56 | -6.7% | Dec 15, 2025 |
| Seaport Global | Tom Curran | $723 | $690.15 | -21.5% | Dec 11, 2025 |
| UBS | Amit Mehrotra | $835 | $713.78 | -9.4% | Dec 10, 2025 |
| Susquehanna | Charles Minervino | $775 | $625.3 | -15.9% | Dec 10, 2025 |
| BMO Capital | Ameet Thakkar | $780 | $625.3 | -15.3% | Dec 10, 2025 |
| RBC Capital | Christopher Dendrinos | $761 | $625.3 | -17.4% | Dec 10, 2025 |
| Oppenheimer | Colin Rusch | $855 | $625.3 | -7.2% | Dec 10, 2025 |
| Barclays | Julian Mitchell | $720 | $601.97 | -21.8% | Dec 4, 2025 |
| Morgan Stanley | Analyst unavailable | $710 | $577.97 | -22.9% | Oct 30, 2025 |
| Jefferies | Julian Dumoulin-Smith | $654 | $585.34 | -29.0% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $660 | $609.65 | -28.4% | Oct 24, 2025 |
| RBC Capital | Christopher Dendrinos | $630 | $586.85 | -31.6% | Oct 23, 2025 |
| BMO Capital | Analyst unavailable | $710 | $576 | -22.9% | Oct 23, 2025 |
| Susquehanna | Analyst unavailable | $750 | $576 | -18.6% | Oct 23, 2025 |
| UBS | Analyst unavailable | $710 | $592.21 | -22.9% | Oct 23, 2025 |
| Morgan Stanley | Analyst unavailable | $690 | $615.95 | -25.1% | Oct 16, 2025 |
| GLJ Research | Analyst unavailable | $758 | $658.98 | -17.7% | Oct 15, 2025 |
| Mizuho Securities | Maheep Mandloi | $677 | $644.41 | -26.5% | Oct 15, 2025 |
| Redburn Partners | Analyst unavailable | $475 | $644.41 | -48.4% | Oct 15, 2025 |
| Susquehanna | Charles Minervino | $740 | $628.36 | -19.7% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $605 | $614.9 | -34.3% | Oct 1, 2025 |
| Melius Research | Analyst unavailable | $740 | $625.55 | -19.7% | Sep 15, 2025 |
| Seaport Global | Tom Curran | $630 | $540.07 | -31.6% | Jul 10, 2025 |
| UBS | Amit Mehrotra | $614 | $517.04 | -33.4% | Jul 7, 2025 |
| Susquehanna | Charles Minervino | $370 | $330.8 | -59.8% | Apr 2, 2025 |
| Truist Financial | Analyst unavailable | $440 | $303 | -52.2% | Mar 27, 2025 |
| RBC Capital | Analyst unavailable | $445 | $317.06 | -51.7% | Mar 18, 2025 |
| New Street | Analyst unavailable | $380 | $316.8 | -58.8% | Mar 5, 2025 |
| Guggenheim | Analyst unavailable | $380 | $316.8 | -58.8% | Mar 5, 2025 |
| BMO Capital | Analyst unavailable | $420 | $315.98 | -54.4% | Mar 3, 2025 |
| Guggenheim | Joseph Osha | $400 | $351.46 | -56.6% | Dec 5, 2024 |
| Mizuho Securities | Maheep Mandloi | $351 | $343.57 | -61.9% | Dec 2, 2024 |
| J.P. Morgan | Mark Strouse | $330 | $295.9 | -64.2% | Oct 24, 2024 |
| RBC Capital | Christopher Dendrinos | $285 | $279.88 | -69.1% | Oct 24, 2024 |
| Goldman Sachs | Joe Ritchie | $324 | $279.88 | -64.8% | Oct 24, 2024 |
| Jefferies | Andrew Tsai | $165 | $274.85 | -82.1% | Oct 21, 2024 |
| Deutsche Bank | Nicole DeBlase | $354 | $272.72 | -61.6% | Oct 21, 2024 |
| RBC Capital | Christopher Dendrinos | $262 | $272 | -71.6% | Oct 18, 2024 |
| Jefferies | Julian Dumoulin-Smith | $336 | $272 | -63.5% | Oct 17, 2024 |
| HSBC | Sean McLoughlin | $255 | $261.61 | -72.3% | Oct 4, 2024 |
| Truist Financial | Jordan Levy | $300 | $255.05 | -67.4% | Sep 26, 2024 |
| Jefferies | Julien Dumoulin-Smith | $293 | $247.39 | -68.2% | Sep 20, 2024 |
| Bank of America Securities | Andrew Obin | $300 | $229.93 | -67.4% | Sep 17, 2024 |
| Mizuho Securities | Maheep Mandloi | $241 | $225.59 | -73.8% | Sep 16, 2024 |
| Barclays | Julian Mitchell | $250 | $225.59 | -72.9% | Sep 16, 2024 |
| Morgan Stanley | Andrew Percoco | $256 | $215.27 | -72.2% | Sep 13, 2024 |
| BMO Capital | Ameet Thakkar | $245 | $215.27 | -73.4% | Sep 13, 2024 |
| Goldman Sachs | Joe Ritchie | $220 | $214.58 | -76.1% | Sep 12, 2024 |
| Jefferies | Julien Dumoulin-Smith | $261 | $192.55 | -71.7% | Sep 3, 2024 |
| HSBC | Sean McLoughlin | $215 | $178.24 | -76.7% | Aug 12, 2024 |
| Morgan Stanley | Andrew Percoco | $220 | $174.03 | -76.1% | Aug 1, 2024 |
| Mizuho Securities | Maheep Mandloi | $208 | $160 | -77.4% | Jul 26, 2024 |
| Daiwa | Dennis Ip | $201.5 | $177.18 | -78.1% | Jun 21, 2024 |
| Argus Research | John Eade | $190 | $177.52 | -79.4% | Jun 13, 2024 |
| RBC Capital | Christopher Dendrinos | $180 | $177.32 | -80.5% | May 30, 2024 |
| Morgan Stanley | Andrew Percoco | $167 | $163.85 | -81.9% | May 23, 2024 |
| Mizuho Securities | Maheep Mandloi | $164 | $151.91 | -82.2% | May 1, 2024 |
| Evercore ISI | James West | $174 | $134.75 | -81.1% | Apr 17, 2024 |
| Raymond James | Patel Molchanov | $160 | $130.07 | -82.6% | Apr 16, 2024 |
| Goldman Sachs | Joe Ritchie | $154 | $131.75 | -83.3% | Apr 16, 2024 |
| Mizuho Securities | Maheep Mandloi | $154 | $134 | -83.3% | Apr 15, 2024 |
| RBC Capital | Christopher Dendrinos | $160 | $140 | -82.6% | Apr 1, 2024 |
Track every rating change on GEV the moment it posts. Free to start.
Start free